Trial
NCT01281254
AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Amgen
Collaborators
—
Condition
Fallopian Tube Cancer
Intervention
AMG386 plus PLD
Why stopped
Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-02